Founder mental health, treated as portfolio risk management.
A fund's return rests on a small number of founders making high-stakes decisions under sustained pressure, with no peer inside the company and a board that evaluates rather than confides. CEREVITY gives platform teams a confidential, founder-first therapy benefit they can stand up across the portfolio, invoiced to the fund rather than routed through any single company's health plan.
Founder mental health is the mental and emotional wellbeing of startup founders under sustained pressure: decision load, isolation, and identity fused to company outcomes. For a VC firm, it is portfolio risk: founder burnout and untreated depression precede slowed execution and abrupt departures. CEREVITY gives platform teams a confidential, private-pay therapy benefit for founders, invoiced to the fund, with no records reaching the company or the board.
What CEREVITY is.
A nationwide network of independent licensed clinicians, offered as a confidential founder-tier benefit a VC platform team sponsors across the portfolio.
CEREVITY is a nationwide network of independent licensed clinicians providing private-pay therapy by secure telehealth across all 50 states. It is not an app, not a coaching marketplace, and not an employee assistance program. Each founder is matched by hand to a clinician experienced with high-visibility, high-responsibility roles, then keeps that clinician for the life of the relationship.
For a fund, the model is simple to reason about. Care is private-pay with no insurance claim filed, so nothing routes through a portfolio company's health plan and no claim record is created anywhere a cap table participant could see it. The benefit is a firm-sponsored line, invoiced to the fund at standard rates rather than administered company by company, and it sits above whatever benefits a portfolio company already runs at the employee level. The result is founder mental health support a founder will actually use, because using it costs nothing in exposure.
CEREVITY runs the same model at adjacent stages of the venture pipeline. Startup mental health support for accelerators and studios covers founders earlier, at the pre-seed and cohort stage, and founder burnout covers the same population when a Series A to C company buys the benefit for itself rather than through a fund.Why founder mental health is different from a portfolio company's usual benefit.
The pressure is structurally different, and a standard employee benefit was never built to reach the one or two people whose judgment moves the outcome.
A founder carries the company's decisions, the board's expectations, and the team's morale as one undifferentiated weight, against a runway with a visible end date. Unlike an employee, a founder usually has no manager to escalate to and no peer role inside the company. That isolation is structural rather than a personality trait, and it compounds every quarter the fund and the board mark progress against a plan.
The link between founder wellbeing and portfolio outcomes is not speculative to the people who invest professionally; it is documented in the clinical research literature on entrepreneurs as a population, and it echoes what founders themselves report about having no peer support system to bring the strain to.
of entrepreneurs report a lifetime history of at least one mental health condition, compared with 32% of a matched non-entrepreneur comparison group. Source: Freeman, M.A., Staudenmaier, P.J., Zisser, M.R., & Andresen, L.A. (2019). The prevalence and co-occurrence of psychiatric conditions among entrepreneurs and their families. Small Business Economics, 53, 323-342.
Entrepreneurs report meaningfully higher rates of mental health conditions than a matched comparison population, and the difference shows up long before a founder is in visible crisis: in slower decisions, in a defensive relationship with the board, and eventually in an exit the fund did not choose. The hidden cost of an untreated founder or CEO compounds quietly long before it becomes a departure announcement.
A generic EAP, designed for high-volume, low-acuity employee support at a single company, is a poor structural fit here for two reasons. First, most portfolio companies below a certain size do not offer one at all. Second, even where an EAP exists, a founder will rarely route something this sensitive through a benefit administered by their own company, in a room they may sit on the other side of within a year. Isolated leaders wait far longer than they should before reaching out, a pattern our 2026 Executive Confidant Gap Report documents directly. The fund is often the only party positioned to sponsor a channel a founder will actually trust.
What founders actually bring to the work.
The presenting issues behind the metrics, in the language founders use about themselves.
Runway pressure
A capital clock that never stops. Every decision is shadowed by a finite runway and the next fundraise, and that sustained urgency is the exact pattern high-stakes anxiety was built to treat.
Isolation at the top
No peer inside the company, and a board that evaluates rather than confides. Founders carry hard calls alone in exactly the pattern leadership isolation therapy exists to address, and it is often worse for a solo founder with no co-founder to share the weight.
Identity fused to the company
For a founder, the company's outcome and the founder's sense of self are rarely separable. A down round or a stalled metric reads as a verdict on the person, not just the business, and that fusion is treated directly in therapy where a founder's identity is the business.
Board and investor scrutiny
Performance is reviewed continuously by people who can remove the founder from the company they built. That oversight, however constructive, removes the safety to say a plan is not working before burnout's impact on productivity forces the conversation instead.
Imposter syndrome under a spotlight
The gap between the confident version of the founder a raise requires and the private uncertainty behind it widens with every round. Founder imposter syndrome is one of the most common presenting issues in this population.
Fundraise anxiety
A raise concentrates months of financial and reputational stakes into a handful of pitch meetings. Anxiety after raising capital is a distinct clinical pattern from anxiety before it, and both surface in this program.
Co-founder and team strain
The working relationship a company depends on most, the founding team, is rarely given anywhere to process strain before it becomes a resignation or a split. Building the capacity to sit with that strain is what structured resilience work is for, not a personality fix applied after the fact.
Relationship strain at home
Fundraising cycles and product deadlines do not pause for a marriage or a family. Couples therapy is part of the network for exactly this reason, and it is one of the more frequently used formats among founders in the program.
A cap table survives a bad quarter. It does not automatically survive a founder who has quietly stopped functioning. Confidential care is the difference between the two.
Session formats built for a founder's calendar.
Three lengths, no rigid weekly slot.
The steady cadence of ongoing therapy. Most clients spend most of their care in 50-minute sessions.
For work that needs more room than a standard hour can hold. See 90-minute sessions.
For work that needs uninterrupted time to reach resolution. See 3-hour therapy intensives.
Care is delivered in 50-minute, 90-minute, and 3-hour sessions by secure telehealth, nationwide. A founder mid-raise or mid-launch can use a single longer block rather than committing to a standing weekly hour a fundraising calendar will break within a month. Continuity is preserved because the founder keeps the same clinician throughout, and format is matched at intake rather than assigned by default. When a situation is urgent, such as the days around a hard board conversation or a failed raise, same-week access is the norm rather than the exception.
Protect the one or two people the thesis depends on.
A confidential conversation about a founder-facing benefit takes one call. Nothing about it touches a portfolio company's health plan or its cap table.
Start a partnership conversationHow a founder is matched.
Every founder is matched by hand, not routed through an intake form and an algorithm.
The eligible individual submits a confidential intake form covering presenting issues, modality preference, professional context, and scheduling parameters. Operated by CEREVITY directly, not by a broker.
Intake is reviewed by CEREVITY's clinical leadership against the network's active capacity, current licensure footprint, and modality availability. This is the step that does not exist in an EAP.
A specific clinician is matched to the founder, who receives the match with the clinician's profile, modality, and credentials, plus a direct online scheduling link.
Scheduling runs directly through CEREVITY infrastructure with no phone handoff. First sessions are typically scheduled within 5 to 10 business days of the match.
Care continues on the cadence the clinical work requires, in 50-minute, 90-minute, or 3-hour sessions, without an employer-imposed session cap.
Capability comparison for VC firms & portfolios.
An evaluation framework on the dimensions that matter when scoping a founder-facing benefit. All three models have a place; they are built for different populations and different levels of visibility.
| Dimension | Typical EAP | Executive-tier platform | CEREVITY |
|---|---|---|---|
| Network model | Broker layer between employer and contractor roster | Single-vendor platform, W-2 or contracted pool | Independent clinical network with direct relationships |
| Clinician assignment | First contractor to reply with availability | Algorithmic matching on intake-form inputs | Clinical review by network leadership |
| Intake and scheduling | Phone handoff to the clinician's line | App-based intake and scheduling | Network-operated intake, direct online scheduling |
| Session formats | Standard 50-minute, capped session counts | Standard 45 to 50-minute sessions | 50-minute, 90-minute, and 3-hour formats, no cap |
| Clinical scope | Acute, broadly applicable concerns | Workforce-wide, executive tier as an upsell | Built around the presenting issues of founders |
| Modality fit | Generalist talk therapy | Generalist therapy with some specialty | CBT, DBT, psychodynamic, IFS, matched at intake |
| Reach | National via roster density | National telehealth, roster variance | All 50 states via telehealth |
| Payment model | Employer-sponsored, in network | Per-employee-per-month seat pricing | Private pay, out of network, partnership agreement |
| Fund visibility | Aggregate, broker-mediated | Vendor dashboards with engagement metrics | Administrative reporting only |
| Right fit for | Workforce-wide acute support | Mid-tier ongoing care with an executive add-on | VC firms & portfolios, end to end |
If you are running a formal evaluation across multiple vendors, our notes on what to look for in a private therapy provider cover the procurement side in detail.
What the fund sees, and what it does not.
For a founder-facing channel to work, the founder has to trust that using it creates no visibility a board member, a co-founder, or a future acquirer could ever see. CEREVITY is built around that requirement.
- Confirmation that contracted services were provided to eligible individuals.
- Aggregate utilization at the partnership level, where contractually appropriate.
- Invoicing and eligibility reconciliation.
- Nothing tied to a specific named founder's clinical content.
- Whether a specific named founder has scheduled, attended, or engaged.
- What clinical issues are being addressed, or which clinician is assigned.
- Session notes, treatment plans, or diagnostic information.
- Any attendance detail at the individual level.
Clinicians are independent licensed professionals operating under their own licensure and the confidentiality and privacy obligations that attach to it. Protected health information is held within the clinical infrastructure, and the agreements governing it are defined in writing before the partnership goes live. Our notice of privacy practices and privacy policy are published in full.
Clinical records, session content, and individual engagement data sit inside the clinical platform. The administrative layer the partner interacts with is structurally separate from the clinical layer.
Eligibility lists are maintained on the partner side and confirmed at the point of intake. Administering eligibility does not require the partner to receive clinical information back.
A Business Associate Agreement is executed where the partnership structure requires it, and whether one applies is a determination made with counsel rather than assumed. The partnership agreement defines the administrative reporting scope in writing before anything goes live. See also our terms of service.
Founders heading into a next round or an acquisition process ask about downstream exposure before they will engage at all. The question that comes up most is whether therapy shows up on a background check. It is answered directly on our site, and the same logic applies to acquirer diligence.
What the first 30 days look like.
The hardest part of a portfolio-wide partnership is not the contract. It is the period between signature and the first founder in care.
A 60-minute kickoff with your team and CEREVITY's partnership lead. We confirm the partnership shape, the eligibility model, the administrative reporting scope, and the internal owner. The BAA, where applicable, is executed.
Your team provides the eligible-individual list. CEREVITY confirms it against the network and establishes the verification path at intake. Only eligibility confirmation flows forward.
CEREVITY provides a confidential, portfolio-wide comms template explaining the benefit, the privacy posture, and how to access intake. It is written to be received without stigma.
Eligible individuals begin intake on their own cadence. First sessions are typically scheduled within 5 to 10 business days. By day 30 the partnership is operational and a quarterly review cadence is in place.
The business case for the fund.
Founder continuity, decision quality, and recruiting are the levers, and they are the levers a fund's return already runs on.
Continuity through the hold
A founder's abrupt departure resets a company's execution at exactly the moment a fund's thesis depends on it holding steady. Confidential clinical care reaches founders before the strain becomes a resignation, catching what founder burnout early warning signs describe well before they become a departure.
Better decisions under pressure
Judgment, risk tolerance, and negotiating posture all degrade under chronic, unmanaged stress, and the decline is measurable well before a founder names it out loud. Part of the reason it goes untreated is structural: high performers avoid therapy at higher rates than the population they outperform, which is exactly why a sponsored, low-friction channel matters.
Recruiting and platform differentiation
A fund that offers a confidential mental health benefit signals to founders, at the term sheet stage and after, that the platform treats them as the asset the fund is actually betting on. That reputation compounds across a portfolio, especially given that most high achievers report that success made them lonelier, not less so.
Questions funds and platform teams ask first.
What does a founder mental health benefit actually include?
A confidential, private-pay therapy benefit for founders across the portfolio, delivered by secure telehealth in all 50 states in 50-minute, 90-minute, and 3-hour session formats. Each founder is matched by hand to a licensed clinician experienced with founder-stage pressure, and the fund is invoiced directly rather than the arrangement running through any single portfolio company's payroll or health plan.
Does this replace an existing EAP at our portfolio companies?
No. Where a portfolio company already runs an EAP, this sits above it as a founder-tier channel, reserved for the one or two people whose continuity most affects the fund's outcome. Where a company has no EAP at all, which is common below a certain headcount, this is often the only structured mental health benefit in place. See why executives do not use your EAP and what to offer instead.
Is therapy for founders different from therapy for entrepreneurs generally?
Clinically, the presenting issues overlap closely: isolation, identity fusion with the company, and sustained decision pressure. What differs for a venture-backed founder is the audience that pressure plays out in front of, a board and a cap table rather than a solo balance sheet, which is why matching accounts for stage and funding structure, not just industry.
How is confidentiality protected from the board and the fund?
Care is private pay, so no insurance claim is filed and nothing routes through a portfolio company's records. The fund receives invoicing and aggregate utilization only, never anything tied to a named founder's clinical content or whether a specific founder is in care. Sessions remain between the founder and the licensed clinician, who is bound by their own licensure confidentiality obligations.
Which founders does the benefit typically cover?
Scope is set in the partnership agreement. Most funds start with CEOs and co-founders across the active portfolio, and some extend it to a founder's spouse or partner through the couples therapy format. The benefit is deliberately founder-first so it stays fast to stand up across a portfolio of varying sizes.
How quickly can a founder be matched to a therapist?
Once the partnership is in place, a founder referred into the program is matched by hand to an appropriate clinician, typically within the same week depending on licensure footprint and modality fit. First sessions are usually scheduled within 5 to 10 business days of the match, and matching is reviewed by CEREVITY's clinical leadership rather than assigned algorithmically.
What does a founder mental health benefit cost a fund?
Structure is agreed in the partnership conversation and depends on portfolio size and the scope of access. CEREVITY is a private-pay network with transparent, standard rates, so there are no insurance-driven surprises in the accounting and no group-rate negotiation involved. Individual session rates are published on our pricing page.
How do we start a partnership?
Start a partnership conversation using the form on this page, by phone at (562) 295-6650, or through the contact page. A member of CEREVITY's clinical leadership will follow up directly and confidentially to scope a benefit that fits the portfolio.
Start a partnership conversation.
Tell us about the fund and the founders you want to support. A member of CEREVITY's clinical leadership will follow up directly and confidentially.
Further reading and related partnerships.
Research, clinical writing, and the other verticals CEREVITY supports.
Research and reports
For funds and platform teams
Clinical writing on founders
A note on sources.
The lifetime mental health condition prevalence figure is drawn from Freeman, Staudenmaier, Zisser, and Andresen (2019), published in Small Business Economics, a peer-reviewed study comparing 242 entrepreneurs against a matched comparison group of 93 non-entrepreneurs. The structural argument on this page, that founder isolation and decision fatigue are functions of the role rather than the person, is based on the firsthand clinical experience of CEREVITY clinicians who work with venture-backed founders, combined with publicly available fund and accelerator program materials. Specific contractual scopes, including any Business Associate Agreement, are confirmed in writing in the partnership agreement before a partnership goes live. Additional CEREVITY research is collected in the knowledge base.